Roger Bentanachs
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Bempedoic acid attenuates vascular inflammation and oxidative stress in a preclinical model of abdominal aortic aneurysm.
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: July 21, 2025
Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD.
Journal: Pharmacological research
Published: May 27, 2025
Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition.
Journal: Frontiers in pharmacology
Published: December 18, 2024
FTO inhibition mitigates high-fat diet-induced metabolic disturbances and cognitive decline in SAMP8 mice.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 01, 2024
Pemafibrate abrogates SLD in a rat experimental dietary model, inducing a shift in fecal bile acids and microbiota composition.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 22, 2024
Adipose Tissue Protects against Hepatic Steatosis in Male Rats Fed a High-Fat Diet plus Liquid Fructose: Sex-Related Differences.
Journal: Nutrients
Published: July 26, 2023
Bempedoic Acid Restores Liver H2S Production in a Female Sprague-Dawley Rat Dietary Model of Non-Alcoholic Fatty Liver.
Journal: International journal of molecular sciences
Published: November 29, 2022
KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid.
Journal: Biomedicines
Published: June 02, 2022
ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model.
Journal: Molecular nutrition & food research
Published: December 09, 2021
Bempedoic acid as a PPARα activator: new perspectives for hepatic steatosis treatment in a female rat experimental model.
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: June 04, 2021
Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation.
Journal: Nutrients
Published: September 21, 2020
Last Updated: 09/26/2026